News Chart Theriva Biologics, Inc.

Equities

TOVX

US87164U4094

Market Closed - Nyse Other stock markets 04:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
0.374 ^USD	+0.81%		-7.43%	-13.04%

May. 07	Theriva Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 23	Theriva Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma	CI

58105038626d513.7qKLBQ0-phShBKxKfta-TrItGqVATX2R0d2zy40NDPY.3Or9KHQK63jQQ-BzEIbRGNYUKNMwfCWi5bT_j-VYQcaB9chwXU_PdeBMmA~298b5407cd774d84f4082dcf61f46dc9